Archive: 18/04/2017

Expert endorses genetic testing for BRCA1 and BRCA2

Professor Kelly Metcalfe, of U of T's Lawrence S. Bloomberg Faculty of Nursing, is leading the charge against hereditary breast and ovarian cancers by helping establish the standard protocol for addressing cancers associated ...

Promising new drug development could treat cachexia

According to the National Cancer Institute, nearly one-third of cancer deaths can be attributed to a wasting syndrome known as cachexia. Cachexia, an indicator of the advanced stages of disease, is a debilitating disorder ...

page 6 from 7